GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Total Inventories

American Cryostem (American Cryostem) Total Inventories : $0.02 Mil (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Total Inventories?

American Cryostem's total inventories for the quarter that ended in Jun. 2022 was $0.02 Mil. American Cryostem's average total inventories from the quarter that ended in Mar. 2022 to the quarter that ended in Jun. 2022 was $0.02 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. American Cryostem's Net-Net Working Capital per share for the quarter that ended in Jun. 2022 was $-0.07.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. American Cryostem's Days Inventory for the three months ended in Jun. 2022 was 374.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. American Cryostem's Inventory Turnover for the quarter that ended in Jun. 2022 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. American Cryostem's Inventory-to-Revenue for the quarter that ended in Jun. 2022 was 0.48.


American Cryostem Total Inventories Historical Data

The historical data trend for American Cryostem's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Total Inventories Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.03 0.03 0.02 0.02

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.02 0.02 0.02

American Cryostem Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


American Cryostem  (OTCPK:CRYO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

American Cryostem's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2022 is

Net-Net Working Capital Per Share (Q: Jun. 2022 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.003+0.75 * 0.015+0.5 * 0.022-2.935
-0-0)/44.1819
=-0.07

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

American Cryostem's Days Inventory for the three months ended in Jun. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2022 )/Cost of Goods Sold (Q: Jun. 2022 )*Days in Period
=0.0205/0.005*365 / 4
=374.13

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

American Cryostem's Inventory Turnover for the quarter that ended in Jun. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2022 ) / Average Total Inventories (Q: Jun. 2022 )
=0.005 / 0.0205
=0.24

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

American Cryostem's Inventory to Revenue for the quarter that ended in Jun. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=0.0205 / 0.043
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


American Cryostem Total Inventories Related Terms

Thank you for viewing the detailed overview of American Cryostem's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915